A Trial to Assess Safety and Efficacy of Topical MBN-101 in Patients With Moderate/ Severe DFI

NCT02723539 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Foot Infection

Interventions

DRUG: MBN-101
DRUG: Placebo

Sponsor

Microbion Corporation